During the past decade, Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" #1 sponsor was "Ethicare GmbH" with 3 trials, followed by "Xeltis" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Javelin Medical" with 1 trials sponsored and "Pi-cardia" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" #1 collaborator was "Genae" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" are "Congenital Heart Disease" (3 trials), "Heart Failure" (3 trials), "Dilated Cardiomyopathy" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Aortic Valve Stenosis" (1 trials). Many other conditions were trialed in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" in a lesser frequency.

Most popular intervention types in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" are "Device" (4 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enalapril Orodispersible Minitablet" (3 trials), "Bioabsorbable Pulmonary Valved Conduit (PV-001)" (1 trials), "Leaflex™ Performer" (1 trials), "OMT" (1 trials) and "Standard of care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".